Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

Targeting specific T cells may help treat alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The humanized AA mouse model is better for testing new alopecia areata treatments.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Innate lymphoid cells type 1 may contribute to alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Fetal skin has unique immune cells different from adult skin.

A new mouse model for vitiligo helps study immune responses and potential treatments.

NK cells play a role in skin diseases like eczema and psoriasis.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

COVID-19 infection may trigger alopecia areata in some patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.